Search results for

Over the last four years, the Chinese trade mark authorities and the courts have become far more willing to recognize well-known trade marks. Samson Yu and Grace Li of Kangxin Partners explain how to get the benefits on offer

WIPO's Madrid system has gained several new members over the past few years, most notably the US and the EU, and it is still growing. Ernesto Rubio of WIPO provides an overview of the latest developments and trends

Concerns over hold-up problems with RAND licensing have raised questions about its use in the IP policies of standards-setting organizations. George W Jordan III offers guidance on avoiding RAND disputes based on a case study of Broadcom v Qualcomm

As more and more multinational companies move R&D facilities and management operations to China, they will inevitably want to file more patent applications there for software-related inventions and business methods. Huang Xiaolin of Liu, Shen & Associates explains how they should go about it

China's rapidly evolving regulatory framework and its increasingly sophisticated courts offer a bright future to pharmaceutical companies looking to invest in China, says Sofia Chen of Bird & Bird

IP owners familiar with patent invalidation procedures in Europe and the US will find many areas of overlap with the rules in China. But there are crucial differences that could affect IP owners' patent strategies, as Tai Hong of China Patent Agent explains

Proposed amendments to the Patent Office's examination guidelines will modernize patent prosecution and clarify some legal grey areas, says Ma Hao of CCPIT Patent and Trademark Law Office

French legislators adopted a new copyright law on March 21 that forces companies to open up digital content to music devices of all makes.

BIO 2006,

New Zealand's existing experimental use exceptions have been established through case law and a Bolar-type provision that was introduced into the Patents Act in December 2002. This provision essentially allows the reasonable use of an invention for the purposes of gaining regulatory approval. The case law attempts to clarify the distinction between research and use of an invention that is not for direct commercial gain, and research and use of an invention that is for commercial gain. The boundary between the two is unclear and at the moment the New Zealand courts are ultimately left to determine what activity constitutes legitimate experimental use and what constitutes infringement.